Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 93 Lymphoid 76 Tumor-Agnostic 2 Sarcoma 2 Myeloid 2 Other 1 Gynecologic 1 Classical hematology 1 CNS 1 Breast 1

Conditions

Ovarian Neoplasms 1 Breast Neoplasms 1

Interventions

Trastuzumab 379 Paclitaxel 369 Cyclophosphamide 338 Docetaxel 314 Capecitabine 198 Doxorubicin 196 Letrozole 184 Tamoxifen 154 Carboplatin 153 Fulvestrant 136 Bevacizumab 129 Anastrozole 120 exemestane 119 Lapatinib 117 Epirubicin 116 Gemcitabine 112 Radiotherapy 107 palbociclib 94 Exercise 87 Fluorouracil 83 Vinorelbine 82 Surveys and Questionnaires 81 pertuzumab 77 Albumin-Bound Paclitaxel 76 Filgrastim 71 130-nm albumin-bound paclitaxel 64 pembrolizumab 63 Everolimus 59 Cisplatin 59 eribulin 58

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Mercaptopurine × Breast × Clear all

NCT01432145 2019-07-09

6MP

University of Oxford

Phase 2 Completed

74 enrolled 13 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡